News
Good Samaritan Medical Center in Brockton is being renamed Boston Medical Center - South (BMC South) and St. Elizabeth's ...
11d
Zacks Investment Research on MSNWhy Globus Medical (GMED) is a Top Growth Stock for the Long-TermFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
Globus Medical GMED has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...
Truist lowered the firm’s price target on Globus Medical (GMED) to $80 from $82 and keeps a Hold rating on the shares as part of a broad research note previewing Q1 results in Medical Technology.
On Thursday, JMP analysts maintained their Market Perform rating for Globus Medical (NYSE:GMED) stock, currently trading at $74.28 with a market capitalization of $10.22 billion. The analysts' stance ...
On Thursday, JMP analysts maintained their Market Perform rating for Globus Medical (NYSE:GMED) stock, currently trading at $74.28 with a market capitalization of $10.22 billion. The analysts ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results